MedPath

湖北东信药业有限公司

Ownership
-
Established
2002-03-04
Employees
-
Market Cap
-
Website
www.tungshun.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

87

NMPA:87

Drug Approvals

Aciclovir Dispersible Tablets

Product Name
阿昔洛韦分散片
Approval Number
国药准字H20094090
Approval Date
Oct 17, 2024
NMPA

Valacyclovir Hydrochloride Capsules

Product Name
盐酸伐昔洛韦胶囊
Approval Number
国药准字H20094061
Approval Date
Oct 17, 2024
NMPA

Valacyclvir Hydrochloride Tablets

Product Name
盐酸伐昔洛韦片
Approval Number
国药准字H20094107
Approval Date
Oct 17, 2024
NMPA

Erythromycin Estolate Granules

Product Name
依托红霉素颗粒
Approval Number
国药准字H20094034
Approval Date
Oct 10, 2024
NMPA

Azithromycin Granules

Product Name
阿奇霉素颗粒
Approval Number
国药准字H20094035
Approval Date
Oct 10, 2024
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20094106
Approval Date
Oct 10, 2024
NMPA

Erythromycin Ethylsuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H20094074
Approval Date
Oct 10, 2024
NMPA

Fibrauretine Suppositories

Product Name
黄藤素栓
Approval Number
国药准字H20093803
Approval Date
Jul 8, 2024
NMPA

Bifonazolen Cream

Product Name
联苯苄唑乳膏
Approval Number
国药准字H20093613
Approval Date
Mar 21, 2024
NMPA

Policresulen Suppositories

Product Name
聚甲酚磺醛栓
Approval Number
国药准字H20093385
Approval Date
Mar 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.